K RZ KANGYAOSHI medical instruments trademark
K RZ KANGYAOSHI medical instruments trademark 29th Mar
IMPEACE Medical Instruments Trademark Registration
The USPTO registered trademark TM98724991 for IMPEACE covering medical, surgical, and orthopedic implants and instruments including spinal fixation screws, bone screws, spine plates, and surgical tools. The trademark application was filed on 2024-08-29 and officially registered on 2026-03-29 for Class 10 medical device goods.
Dog in Covington County confirmed positive for rabies; precautions advised
The Alabama Department of Public Health confirmed a dog in Andalusia (Covington County) tested positive for rabies. A veterinarian submitted the dog for testing after suspecting rabies, and the ADPH Bureau of Clinical Laboratories confirmed the diagnosis. Human exposure occurred, requiring affected individuals to seek medical evaluation. The state reiterates that Alabama law requires dogs, cats, and ferrets 12 weeks of age and older to be current on rabies vaccinations.
Kain Capital Acquires White Wilson Medical Center
McGuireWoods LLP reported that Kain Capital has completed its acquisition of White Wilson Medical Center, an independent multi-specialty physician group based in Fort Walton Beach, Florida. White Wilson operates nine clinic locations with more than 70 providers serving Florida's Emerald Coast. Terms of the acquisition were not disclosed.
Pinnacle MultiCare v. HHS - $31.2M Medicare Recoupment Dispute
Pinnacle MultiCare Nursing and Rehabilitation Center, a Bronx nursing facility, filed a federal action in SDNY on February 26, 2026, to contest HHS's $31.2 million Medicare Part A recoupment demand. OIG cited a 99% error rate in claims submitted during 2020-2021, with HHS demanding repayment by February 27, 2026, plus 12% interest. Pinnacle argues the recoupment violates pandemic-era federal directives and state immunity protections.
Physician Employment Agreements: Five Enforceability Pitfalls
Sheppard, Mullin, Richter & Hampton LLP published an analysis identifying five common pitfalls in physician employment agreements. The article focuses on enforceability challenges with restrictive covenants (non-competes, non-solicits) given the state-by-state patchwork of regulations affecting healthcare employers. The analysis highlights varying state restrictions including outright bans (Alabama, Rhode Island), time limits (Louisiana: 3 years, Connecticut: 1 year), geographic limits (Maryland: 10 miles, West Virginia: 30 road miles), and Texas's buyout clause requirement.
Healthcare Regulatory Update: CMS Claims Rule, Reconciliation, Illicit Drug Legislation
McDermott+ Consulting weekly update covering CMS final rule modernizing claims processing with HIPAA standards for electronic healthcare claims attachments and electronic signatures. Congressional Republicans are discussing 'reconciliation 2.0' legislation with potential healthcare savings; House Energy and Commerce Health Subcommittee reviewed opioid-related bills including the Combatting Illicit Xylazine Act and Alternatives to Pain Act. HHS announced new Healthcare Advisory Committee members and launched the ASPIRE pediatric care coordination model.
FTC Healthcare Task Force targets consolidation, enforcement authority boost
FTC Healthcare Task Force targets consolidation, enforcement authority boost
CMS Nationwide DMEPOS Enrollment Moratorium - Seven Supplier Types
CMS announced a six-month nationwide enrollment moratorium on initial Medicare enrollment for seven categories of DMEPOS suppliers, effective February 27, 2026 through August 27, 2026. The moratorium, the first nationwide DMEPOS enrollment freeze in program history, targets medical supply companies with orthotics, pedorthic, prosthetics, and other specialized personnel. Florida became the first state to implement a parallel Medicaid DMEPOS moratorium on March 25, 2026, signaling potential expansion to other states.
Tennessee gets $206.9M rural healthcare transformation funding
Tennessee gets $206.9M rural healthcare transformation funding
AI Scribe Legal Risks, Consent Requirements, HIPAA Compliance
JD Supra Healthcare published a legal analysis by McDermott Will & Schulte addressing legal considerations for healthcare providers deploying AI scribes. The article covers state recording consent laws (noting over a dozen all-party consent states), HIPAA implications, biometric consent issues related to voiceprint features, and vendor liability considerations for third-party AI platforms.
Canada Launches Pharmaceutical and Life Sciences Sector Task Force
Health Canada and Innovation, Science and Economic Development Canada announced the creation of the Pharmaceutical and Life Sciences Sector Task Force on March 18, 2026. The joint initiative will explore made-in-Canada solutions to enhance competitiveness and improve access to pharmaceutical products while reducing regulatory burden. The task force builds on Health Canada's ongoing Red Tape Review and will include pharmaceutical and biotechnology stakeholders.
Q1 2026 Healthcare Consolidation Legislation Recap
Holland & Knight's Q1 2026 recap summarizes proposed federal and state legislation affecting healthcare consolidation. Key federal developments include the successful challenge to FTC's Hart-Scott-Rodino rules (returning to old rules pending appeals) and FTC Chair's March 20, 2026 memorandum establishing a Healthcare Task Force. State legislatures have expanded scrutiny beyond private equity to include REITs, MSOs, and health insurers, with states revisiting corporate practice of medicine doctrine. Of 12 tracked bills, only 2 passed while 10 stalled.
Prostate Intelliscore Medical Diagnostic Trademark Application
The USPTO received a trademark application (TM99033032) for 'Prostate Intelliscore' on February 7, 2025, filed under Intent to Use provisions. The application covers medical testing services, liquid biopsy testing, and diagnostic kits for disease detection including cancer. This is a routine trademark registration filing with no immediate regulatory obligations for other parties.
Trademark Application - Rejuvenation Wellness (Class 044)
USPTO received an Intent to Use trademark application TM98206553 for 'REJUVENATION WELLNESS' covering wellness services, health-related consulting, health spa services, and dietary supplements in Class 044. The application was filed on October 2, 2023, establishing priority rights for the mark. No opposition period or compliance deadlines are specified for third parties.
All In One Smile dental services trademark application
USPTO received an Intent to Use trademark application TM98599168 for "ALL IN ONE SMILE" covering dental implant surgery services, advertising and business management consultancy, and dental bridges under Class 044. The application was filed on June 13, 2024.
XSENSE Trademark for Cryoablation Medical Devices
USPTO received Intent to Use trademark application TM97544323 for XSENSE covering Class 10 cryoablation medical devices including surgical probes, catheters, cryotherapy consoles, and applicators. The applicant seeks to protect the mark for use with cryosurgical apparatus, cryoablation needles, medical balloons, and aerosol dispensers for cryogenic treatment delivery. No compliance action required.
Medignix trademark for medical mobility and assistive devices
The USPTO received a trademark application for MEDIGNIX (Serial No. TM98666943) filed on July 25, 2024, under Intent-to-Use provisions. The application covers Class 010 medical devices including crutches, walking aids, walking frames, commode chairs, and bathtub rails adapted for persons with disabilities.
GAIN trademark includes haemostats, cervical collars, medical gloves
The USPTO published trademark application TM98820521 for GAIN covering medical devices including haemostats, cervical collars, medical gloves, and other goods in Nice Classification 10. The application was filed on October 25, 2024, and published for opposition on March 29, 2026.
ZIROSSTEE Trademark Application - Medical Devices Class 10
USPTO published trademark application TM99074696 for ZIROSSTEE covering medical implant products including biodegradable bone fixation implants, surgical implants, orthopedic joint implants, artificial bones, dental implants, and related devices in International Class 10. The application was filed March 9, 2025, under intent-to-use basis with the declaration published March 29, 2026.
WARABLE Trademark - Medical Monitoring Devices
USPTO published the WARABLE trademark application (TM99506385) for opposition on March 29, 2026. The mark covers medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, combined with a mobile device app and cloud-based AI interpretation tools. The application was filed on November 23, 2025.
Dental Mixing Tips Trademark - Class 10
The USPTO published trademark application TM97189180 for dental mixing tips and cartridges used with dispensers for multi-part dental compositions. The application was originally filed on December 24, 2021, and published for opposition on March 29, 2026. Third parties have a 30-day window to file oppositions based on likelihood of confusion with existing registrations.
BLINKJOY trademark for rechargeable heated eye mask
USPTO published trademark application TM98625539 for BLINKJOY, covering rechargeable heated eye masks for therapeutic purposes including moisture-retaining sleep masks for dry eyes. The application was filed on June 28, 2024, under Intent to Use basis with a stated intent-to-use date of March 29, 2026.
Salmonella Warning for Easter Poultry Purchases
The New Mexico Department of Health issued a public health warning on March 30, 2026, advising against gifting chicks and ducklings for Easter due to Salmonella infection risks. The warning highlights that children under 5 face the highest risk of serious infection, as poultry can shed Salmonella bacteria even when appearing healthy. NMDOH reports 100-130 annual Salmonella cases in New Mexico, while CDC estimates 1.35 million US infections yearly.
Medicare Home Health Agency Provider Compliance Audit: VNS Health
HHS OIG completed a compliance audit of VNS Health's Medicare home health claims for the period July 1, 2020, through June 30, 2022. Of 100 sampled claims, 16 contained errors resulting in $2,965,484 in overpayments. OIG recommends VNS Health refund the overpayments and conduct internal audits to identify similar billing errors.
FACECO Trademark - Medical and Cosmetic Services
USPTO received trademark application TM98548680 for FACECO filed on May 13, 2024, under Intent-to-Use basis. The application covers medical and cosmetic skin care services, massage therapy services, and cosmetics. The services span training, consultation, and direct service delivery in massage and skin care procedures.
COMEBACK CORNER Trademark Application for Fitness Goods and Services
The USPTO received a trademark application for COMEBACK CORNER (Serial No. TM97849628) under Intent-to-Use basis filed on March 21, 2023. The application covers fitness and health-related services including a website with fitness information and blogs, as well as clothing items such as sweatshirts, athletic wear, and headwear. No compliance actions are required from trademark applicants or the public at this stage.
LASERIE Trademark Application for Medspa Services
The USPTO received an Intent-to-Use trademark application (TM98515921) for 'LASERIE' covering medspa services for health and beauty of the body. The application was filed on April 23, 2024, by a party seeking to register the mark under Class 44 for medical spa services.
Lifecath PICC Easy Central Venous Catheter Lot Recall
ANSM issued safety alert R2608397 regarding a product recall by Vygon Germany GmbH for Lifecath PICC Easy central venous catheters. The recall affects specific lots distributed to French pharmacies and health establishments. Healthcare facilities must identify and return affected products immediately.
Philips Respironics Trilogy Evo Ventilator Safety Alert - Nebulizer Use and Software Update
ANSM issued a safety alert (Ref. R2604745) requiring Philips Respironics Trilogy Evo, Trilogy Evo O2, and Trilogy EV300 ventilators to receive mandatory software updates and discontinue use of non-pneumatic nebulizers. The alert addresses incorrect tidal volume delivery when non-pneumatic nebulizers are used due to faulty leak estimation, and corrects alarm delay delays and flow sensor anomalies caused by aerosol accumulation. Healthcare providers and home health service providers (PSAD) must act immediately.
Safety alert Orbis Medication 3.x prescription software
Safety alert Orbis Medication 3.x prescription software
Sphere-9 Dual-Energy Mapping and Ablation Catheter Safety Recall
ANSM has recorded a field safety corrective action by Medtronic for the Sphere-9 dual-energy mapping and ablation catheter system (combining electroporation and radiofrequency) under reference R2608484. Healthcare establishments must review the Medtronic safety letter and take appropriate action regarding affected devices.
TruPulse Ablation Generator Safety with Thermocool Catheter
ANSM issued safety notification R2608394 regarding a field safety corrective action by Biosense Webster Inc. for the TruPulse cardiac ablation generator (software version 2.7.0) when used with the Thermocool SmartTouch SF dual-energy catheter. Healthcare facilities using this equipment must review the manufacturer's safety communication dated March 30, 2026.
SureForm 30 8mm Surgical Stapler Recall
ANSM issued safety alert R2607062 regarding Intuitive Surgical's voluntary recall of SureForm 30 8mm Gray Reload surgical stapler devices. The recall affects hospital pharmacies and surgical departments using computer-assisted surgery systems. Healthcare facilities must identify and remove affected devices from use.
MEDISTEP Trademark Application - Medical Devices and Gait Analysis
The USPTO published trademark application TM79440639 for MEDISTEP covering medical devices including gait analysis apparatus, diagnostic measuring devices, and health management software including SaMD. The application was filed November 24, 2025, and published March 29, 2026, initiating a three-month opposition period during which third parties may challenge the registration.
VEGA EFFECT - Medical Laser Device Trademark Application
USPTO published trademark application TM79419312 for VEGA EFFECT covering medical and veterinary laser devices for incision, excision, ablation, vaporization, and coagulation of body tissues. The application was filed on February 20, 2025, and was published for opposition on March 29, 2026. Third parties have until May 13, 2026 to file an opposition.
DR.870 Medical Device Trademark Published for Opposition
The USPTO published trademark application TM79441720 for DR.870 covering medical devices (Class 10) including vibromassage apparatus, medical instruments, surgical dressings, and various pharmaceutical/cosmetic goods. The trademark was filed on November 24, 2025, and published for opposition on March 29, 2026, initiating a 30-day opposition period during which third parties may challenge the registration.
EK SA Trademark for Dental Devices and Implants
USPTO published trademark application TM79429327 for "EK SA" covering dental devices and implants. The application includes endoprostheses, surgical implants, dental instruments, artificial teeth, and denture materials under Nice Class 10. The opposition period opened March 29, 2026.
WELLSYSTEM REDWAVE Trademark Application Published for Opposition
USPTO published trademark application TM79434872 for WELLSYSTEM REDWAVE on March 29, 2026. The application covers medical devices including red-light therapy apparatus, infrared light therapy devices, vibrating therapeutic apparatus, and wellness equipment for medical purposes. Third parties who believe this mark conflicts with their existing trademarks may file an opposition.
South Dakota Maternal and Infant Health Task Force Five-Year Strategic Plan
The South Dakota Department of Health and Maternal and Infant Health Task Force released a five-year strategic plan (2026-2030) aimed at improving maternal and infant health outcomes statewide. The plan establishes three priority areas: postpartum care, safe sleep education, and systems of care to improve access and coordination. Key data from a 10-year review (2015-2024) of pregnancy-associated and infant deaths informed the plan's strategies.
BERNIER PHARMACEUTICALS Trademark Application - Cosmetics and Pharmaceutical Skin Care Products
USPTO published trademark application TM79441446 for BERNIER PHARMACEUTICALS covering cosmetics and pharmaceutical preparations including skincare products, acne treatments, and vitamin preparations. The application was filed November 24, 2025, and published March 29, 2026, initiating a standard 30-day opposition period during which third parties may challenge the registration.
BC Health Professions Regulatory Reform - New HPOA Framework
British Columbia is replacing the Health Professions Act (HPA) with the Health Professions and Occupations Act (HPOA), effective April 1, 2026. The new legislation establishes a Health Professions and Occupations Regulatory Oversight Office (Superintendent's Office) to oversee six health regulatory colleges, marking a significant shift from self-regulation to government-driven oversight. The HPOA introduces new bylaws requirements, prescribed licensee duties, and establishes a dedicated Discipline Tribunal.
Rhode Island SPA 25-0013, Cell Gene Therapy reimbursement, hospitals, Acquisition Cost
Rhode Island SPA 25-0013, Cell Gene Therapy reimbursement, hospitals, Acquisition Cost
Ohio Medicaid Alternative Benefit Plan Agency Name Change
The Centers for Medicare & Medicaid Services approved Ohio State Plan Amendment 25-0031, which updates the Alternative Benefit Plan to reflect an agency name change. The Ohio Department of Mental Health and Addiction Services has been renamed to the Ohio Department of Behavioral Health. The amendment was approved on March 26, 2026, with an effective date of November 1, 2025.
Massachusetts Adult Foster Care Reimbursement Rates
CMS approved Massachusetts State Plan Amendment MA-25-0034 updating Adult Foster Care (AFC) reimbursement rates effective November 1, 2025. The amendment supersedes the previous version (24-0029) and establishes new fee-for-service rates published under Massachusetts regulations 101 CMR 351.00. All AFC providers delivering services under Massachusetts Medicaid must use the updated rates for services rendered on or after the effective date.
NY Medicaid SPA 25-0053 - Inpatient Drug Reimbursement Carve-Out
CMS approved New York Medicaid State Plan Amendment 25-0053, which carves out select drugs administered in inpatient hospital settings from bundled inpatient payment rates for separate reimbursement. The amendment takes effect October 1, 2025. Affected drugs will be reimbursed per Attachment 4.19-B Prescribed Drugs sections. Providers are prohibited from using 340B inventory for carved-out drugs.
Ohio SPA 25-0030 Approves Agency Name Change
CMS has approved Ohio State Plan Amendment (SPA) 25-0030, which amends Attachments 3.1-A and 4.19-B to reflect the administrative name change of the Ohio Department of Mental Health and Addiction Services (MHAS) to the Ohio Department of Behavioral Health (DBH). The amendment was approved on March 26, 2026, with an effective date of November 1, 2025.
Hospital Drug Reimbursement Carve-Out Under Medicaid
CMS approved New York SPA 25-0064, effective October 1, 2025, which carves out select drugs provided in a hospital setting from inpatient payments and reimburses them separately under the state's Prescribed Drug methodology. The amendment affects Attachment 4.19-B pages 4(d)(1) and 4(d)(2) of New York's Medicaid State Plan.
Easter 2026 Office Closure Notice
Care Inspectorate Wales (CIW) has announced its Easter 2026 holiday closure schedule. The office will be closed on Good Friday 3 April and Easter Monday 6 April 2026, resuming normal hours on Tuesday 7 April. Stakeholders requiring urgent assistance during the closure period are directed to CIW's online reporting form.
Truva Trademark Application Published for Opposition
USPTO published trademark application TM79440897 for "TRUVA" in Class 044 (Medical Services) on March 29, 2026. The application covers medical services including healthcare, hearing aid fitting and repair, diagnostic services, telemedicine, and medical screening. The filing date was December 2, 2025.
K Trademark - Mental Health SaaS Services
USPTO published trademark application TM79436922 for 'K' covering mental health SaaS services including software for scheduling and managing mental health information, downloadable applications, and mental health therapy and counseling services. The application was published for opposition on March 29, 2026, opening a 30-day window during which third parties may challenge the registration.
SDI Trademark Application Published for Opposition
USPTO published SDI trademark application TM79438667 for opposition on March 29, 2026. The application covers goods in Nice Classes 9, 10, and 11, including scientific instruments, medical devices, and electronic equipment. The publication initiates a 30-day opposition period during which third parties may file objections.
Cosmy Trademark - Entertainment, Healthcare, and Communications Services
USPTO published trademark application TM79444107 for COSMY on March 29, 2026. The application covers services including entertainment and educational activities, advertising, healthcare and beauty consultancy, and telecommunications/social networking software. Third parties have a 30-day window to file oppositions.
Cardinal Health EP Packs Type I Recall
Health Canada issued a Type I medical device recall for Cardinal Health Cardiac Electrophysiology (EP) Packs containing potentially affected Medline Namic Angiographic Control Syringes. The recall addresses a risk that the syringe rotating adaptor may unwind during use, causing loose connection or full disconnection between the syringe and manifold. Affected products include lots 479584 and 473022 with model number SAN30EP'XXX'.
Glaucoma visual field diagnosis head-mounted display
USPTO published patent application US20260083319A1 for a head-mounted display system implementing adaptive map perimetry for glaucoma visual field diagnosis and monitoring. The system includes a headset device with a display screen, adaptive algorithm, normative database, and spatial mapping to identify damaged visual field clusters. Inventors: Lama Al-Aswad, Iván Marín-Franch, Nicholas Neissa.
Optical Detection of Middle Ear Effusion and Infection via Laser Speckle
The USPTO published patent application US20260083310A1 for an optical detection system using laser speckle imaging to diagnose middle ear effusion and infection. The system employs dual-wavelength light sources and an imaging device sized to fit within a patient's ear canal. Inventors include Claus-Peter Richter, Joaquin Cury, and Jordan Michael Villa.
Oral Health Monitoring Device
USPTO published Colgate-Palmolive Company's patent application US20260083311A1 for an oral health monitoring device. The device incorporates wing structures with dual image sensors enabling simultaneous imaging of multiple tooth surfaces. The application was filed August 28, 2023 and granted A1 publication status on March 26, 2026.
Split Overtube Prevents Loop Formation During Colonoscopy
USPTO published patent application US20260083313A1 for a split overtube device designed to prevent loop formation during colonoscopy. The device features a longitudinal split allowing placement over an endoscope shaft during an ongoing procedure. Invented by Rafal Sadurski, the overtube uses segmented oval openings and a fastening mechanism to create a semi-rigid conduit that translates axial force into forward endoscope movement without dangerous loop formation.
White-Light Source and Intraocular Illumination Device
USPTO published patent application US20260083316A1 for a white-light source and intraocular illumination device with controllable spectral composition. The invention combines multiple light sources (blue, green, red spectral ranges) including laser-activated remote phosphor (LARP) technology for fiber-based intraocular illumination in surgical applications. Application No. 19109457 was filed April 28, 2023, by inventors Doubek, Masini, and Neis.
Visual Field Testing Method and Device
The USPTO published patent application US20260083318A1 for a visual field testing method and device. The invention, filed July 23, 2025, describes a method using display equipment with a detection interface where central and peripheral targets are presented according to preset strategies, with subject responses determining testing results. This affects medical device manufacturers developing diagnostic ophthalmic equipment.
Chemos LLC Bulk Manufacturer DEA Application
The DEA has published a notice regarding an application from Chemtos, LLC to be registered as a bulk manufacturer of various Schedule I controlled substances. Registered manufacturers and applicants can submit comments or requests for a hearing by May 29, 2026.
Pharmaron Manufacturing Services DEA Importer Controlled Substances Application
The Drug Enforcement Administration (DEA) has published a notice regarding an application from Pharmaron Manufacturing Services (US) LLC to be registered as an importer of Poppy Straw Concentrate (Schedule II). Interested parties may submit comments or requests for a hearing by April 29, 2026.
Ablation Zone Prediction System for Surgical Procedures
The USPTO has published a new patent application, US20260083497A1, detailing an ablation zone prediction system for surgical procedures. The system uses functional respiratory imaging data to generate a 3D model and predict the ablation zone, aiming to improve surgical precision.
Meditrina bipolar electrosurgical device for endoscopic surgery
The USPTO has published a new patent application (US20260083493A1) for a bipolar electrosurgical device and method of use, assigned to Meditrina, Inc. The application details devices for cutting, ablating, or coagulating tissue, particularly for endoscopic gynecology procedures.
Steerable Ultrasound Endoscope with Needle Guide Ramp
The USPTO has published a new patent application, US20260083301A1, for a steerable ultrasound attachment for endoscopes developed by EndoSound, Inc. The application details an assembly that includes an ultrasound imaging head, sub-assembly, and a needle guide ramp designed to direct a needle within an imaging slice plane.
Catheter Robot and Human-Machine Interface Patent Application
The USPTO has published a new patent application (US20260083522A1) for a catheter robot and human-machine interface filed by ROBOCATH. The application details a drive module for medical instruments and a control interface with speed and position modes.
Patent Application: In Vivo Tissue Diagnosis Using Optical Spectroscopy
The USPTO has published a new patent application (US20260083331A1) from Florida International University Board of Trustees for devices and methods for in vivo tissue diagnosis using optical spectroscopy and indentation. The application details systems that utilize intrinsic tissue properties to detect disease and injury.
Patent Application: Fluorescence Imaging for Cancer Margin Detection
The USPTO has published a new patent application (US20260083330A1) detailing a method and system for enhanced fluorescence imaging of tissue and cancer margins. The application, filed on September 23, 2024, describes techniques for analyzing tissue using fluorescent agents and biomolecule autofluorescence to identify diseased tissue.
Patent for EEG Analysis using ICA, sLORETA, Source Localization
The USPTO has published a new patent application detailing systems and methods for analyzing electroencephalogram (EEG) signals. The application, filed by Thomas Collura and Agostino Roseace, describes techniques including independent component analysis (ICA), frequency-domain averaging, sLORETA, and source localization for deconstructing EEG rhythms into individual sources and patterns.
US Patent Application: Portable Neck Assessment System
The USPTO has published a new patent application (US20260083371A1) for a portable neck strength assessment system. The system utilizes AI or machine learning models to assess injury risk and includes a wearable head harness and an isometric neck strength device.
Sony Endoscope Optical System Patent Application
The USPTO has published a new patent application from Sony Group Corporation for an optical system for endoscopes. The application details an optical system designed to form images on both visible light and infrared light imaging elements, with specific conditional formulas related to lens expansion coefficients.
Light Source Device and Medical Observation System Patent Application
The USPTO has published a patent application (US20260083309A1) for a light source device and medical observation system. The application was filed on September 7, 2023, and details a device with temperature detection and light emission capabilities for medical use.
Opto-physiological monitoring method and system patent
The USPTO has published a new patent application (US20260083329A1) for a real-time opto-physiological monitoring method and system. The application describes a wearable device that uses optical properties and physical variables to determine physiological properties.
Ultrasonic Surgical Instrument with Clamping Force Sensors Patent Application
The USPTO has published a new patent application (US20260083472A1) for an ultrasonic surgical instrument with integrated clamping force sensors. This innovation aims to provide real-time feedback during robotic surgeries, potentially enhancing precision and safety.
THEODO. Trademark Published for Opposition
The USPTO has published the trademark application for 'THEODO.' for opposition. This trademark application covers a broad range of business IT services, including administrative data processing, business consulting, and e-commerce advice.
CHROVIS Medical Services Trademark Application Published
The USPTO has published the trademark application for CHROVIS, covering a wide range of medical services including cancer screening, diagnosis, and genetic testing. The application was filed on September 19, 2025, and published for opposition on March 29, 2026.
AVACURA Trademark Application - Medical Services and Devices
The USPTO has published the trademark application for 'AVACURA', covering medical devices, physical therapy equipment, and related healthcare and beauty services. The application was published for opposition on March 29, 2026, with a filing date of September 11, 2025.
ENDOMAG trademark status change, medical cancer diagnostics
The USPTO has updated the status of the ENDOMAG trademark (TM79163080) related to medical cancer diagnostics and research services. The filing date for this trademark application was December 15, 2014.
Endosphères Therapy Trademark Registration
The USPTO has registered the trademark 'Endosphères Therapy' (TM79256473) for services including therapeutic massage using a specific electric device and cosmetic skin care services. The trademark was filed on March 19, 2019, and registered on March 19, 2019.
Dizney Behavioral Health - Intent to Use Trademark Application
The USPTO has received an intent-to-use trademark application for 'Dizney Behavioral Health' for services in Class 044, which covers medical services. The application was filed on March 28, 2026, with an intended use date of March 29, 2026.
BIG BLANKET HEALTH Trademark Application - Medical Services
The USPTO has received an intent-to-use trademark application for 'BIG BLANKET HEALTH' for medical services, specifically providing educational information about healthcare. The application was filed on March 28, 2026, with an effective date of March 29, 2026.
STOMADAM medical device trademark application filed
The USPTO has received an intent-to-use trademark application for 'STOMADAM' filed on March 28, 2026. The application covers medical devices, specifically barrier devices for enteral feeding tube sites.
FLOESYLA Trademark Published for Opposition
The USPTO has published the trademark application for 'FLOESYLA' for opposition. The application covers a range of pharmaceutical products, dietary supplements, and related items. The publication date for opposition is March 29, 2026.
Clearsummit Wellness Trademark Application - Supplements
The USPTO has received an intent-to-use trademark application for 'Clearsummit Wellness' on March 28, 2026. The application covers various supplements, including mineral, homeopathic, probiotic, protein, enzyme, and nutritional supplements.